Background: Birth by Cesarean section increases the risk of developing type 1 diabetes later in life;
Background
Type 1 diabetes is an autoimmune disease in which immune cells destroy insulin-producing beta cells in the pancreas. Loss of beta-cell mass leads to insulin deficiency, impaired glucose tolerance, and ultimately the onset of type 1 diabetes [1] . This process is marked by the appearance of islet autoantibodies to beta-cell-related antigens [2] . Autoantibody seroconversion usually occurs during childhood and early adolescence, with a peak conversion rate between 9 months and two years [3] .
Notably, an increasing incidence of type 1 diabetes has been observed within the last few decades, especially in children [4] . Several previous studies indicated transcriptional changes in immune cells caused by the development of islet autoantibodies [5, 6] , indicating substantial molecular changes long before the onset of type 1 diabetes.
Children born by Cesarean section have an odds ratio of 1.23 for the development of type 1 diabetes compared to vaginally delivered children [7] . Moreover, Cesarean section has been reported to be associated with a faster progression to type 1 diabetes, but not with an increase the risk for islet autoimmunity [8] . The underlying mechanisms of these associations are not yet fully understood. Some reports indicate that the mode of delivery affects colonization of microbiota in the intestinal tract [9] , which in turn affects the developing immune system of infants [10] . Such differences in the gut microbiome and its interaction with the immune system may lead to increased risk of asthma, childhood allergies [11] , and autoimmune diseases, such as type 1 diabetes.
Here we investigated the impact of Cesarean section and islet autoimmunity on the immune system by analyzing gene expression data in peripheral blood mononuclear cells (PBMCs) as a readout ( Figure 1A ).
The overall goal of the analysis was to elucidate common immune modulation patterns between an early risk factor, Cesarean section, and the development of autoimmunity. We first investigated the effects of Cesarean section on gene expression profiles of children in the first year of life ( Figure 1B ). To this end, we analyzed data from several time points in this early period in children with an increased familial risk for type 1 diabetes. A generalized additive mixed model was used to account for the longitudinal information when extracting gene expression differences between children born by Cesarean section and vaginal delivery ( Figure 1C) . In a second analysis, we compared gene expression levels of children with increased risk of familial type 1 diabetes after initiation of islet autoimmunity with age-matched children who did not develop islet autoantibodies. We then combined both results to identify genes and pathways that were differentially regulated in both analyses, to link Cesarean section and islet autoimmunity at the level of gene expression. Finally, we compared the patterns identified for Cesarean section and islet autoantibodies with gene expression data from activated human CD4+ T lymphocytes to identify candidates for common molecular mechanisms of immune activation.
Results

Effects of Cesarean section on the transcriptome in the first year of life
To focus on early postpartum effects on genetic regulation after delivery by Cesarean section, we restricted our analysis to samples from children in their first year of life (Supplemental file 1: Figure S1 ).
This resulted in a total of 154 PBMC gene expression samples (71 Cesarean section, 83 vaginal delivery) from 87 children (39 Cesarean section, 48 vaginal delivery), Figure 1A+B . The number of samples per child ranged between 1 and 4 (Supplemental file 1: Figure S1 ). Details on the dataset and preprocessing steps are provided in the Methods section.
We used a generalized additive mixed effect model (GAMM) to account for the longitudinal nature of the dataset. The model consisted of three major parts ( Figure 1C ): (1) the change of expression profiles over time was modeled using a spline-based function, (2) the overall trend of expression values per child was captured by a random mixed effect, and (3) a term representing the Cesarean section effect extracted the association in which we were primarily interested. Applying this model to the data set, we observed an enrichment of low p-values before adjusting for multiple testing (Figure 2A and Supplemental file 2). However, after multiple testing correction by controlling the false discovery rate (FDR) at 0.1, no significant single genes could be identified in this first step ( Figure 2B ).
To improve statistical power and facilitate biological interpretability, we performed a pathway enrichment analysis based on the KEGG pathway database [12] . From this analysis, we obtained two significantly differentially expressed pathways after multiple testing correction (FDR <= 0.1): "Pentose phosphate pathway" and "Pyrimidine metabolism" ( Figure 2C and Supplemental file 2). The "Pentose phosphate pathway" included 27 genes (20 up-and 7 down-regulated genes in children born by Cesarean section) and the "Pyrimidine metabolism" pathway contained 92 genes (57 up-regulated and 35 down-regulated).
Both pathways are well known to be involved in the synthesis of nucleotides during cell proliferation [13, 14] . This indicated that there is a change in expression profiles of proliferation-related nucleotide synthesis pathways as an early consequence of delivery by Cesarean section.
Effects of islet autoimmunity on the transcriptome
To identify gene expression signatures associated with seroconversion, we compared the earliest sample of children after the development of islet autoantibodies (up to 6 months post-seroconversion; 15 children) with all available age-matched samples of children who did not develop islet autoantibodies (74 children). We applied linear regression to explain gene expression differences induced by islet autoantibody status, corrected for age (see Methods). We detected a strong accumulation of differentially expressed genes ( Figure 3A) , of which 3,867 were significant after multiple testing correction (FDR ≤ 0.1, Figure 3B ). The majority of these genes were found to be up-regulated in children with islet autoimmunity (64% up-regulated vs. 36% down-regulated, Supplemental file 2).
Pathway enrichment analysis on KEGG pathways identified 20 as significantly regulated (FDR <= 0.1, Figure 3C and Supplemental file 2). The top-ranked pathways were "p53 signaling pathway", "Ubiquitin mediated proteolysis", and "RIG-I-like receptor signaling pathway." The two significant pathways from the Cesarean section analysis, "Pyrimidine metabolism" and "Pentose phosphate pathway", also appeared as significant in the islet autoantibody analysis. Notably, comparing gene expression samples of children before seroconversion (up to 6 months before) and age-matched children without islet autoantibodies yielded no significant genes or pathways (Supplemental file 3). In addition, we investigated children that had gene expression samples both before and after seroconversion (up to 6 month before and after) in a paired analysis, leaving only seven children. No genes or pathways were found to be differentially expressed (Supplemental file 3).
Taken together, we observed several immune system-related and nucleotide synthesis pathways associated with islet autoimmunity, which included the pathways found in our Cesarean section analysis.
Coherent gene expression changes between Cesarean section and islet autoimmunity
We further investigated the similarities of transcriptional changes between the two risk factors. First, we found that the individual gene regulation of both "Pyrimidine metabolism" and the "Pentose phosphate pathway" pathway showed similar patterns of up-and down-regulation between Cesarean section and islet autoimmunity ( Figure 4A , Supplemental file 4).
Extending this analysis, we quantified the relationship of gene regulation between the two factors at a systematic level. We correlated the standardized effects from Cesarean section and development of islet autoantibodies across all genes ( Figure 4B ), revealing a striking correlation of 0.606 (p = 0.0062, Figure   4C ). In other words, genes regulated by Cesarean section, despite the rather weak signal strength in our study, were also regulated in the same direction by the initiation of islet autoimmunity. A similar correlation between the effects of Cesarean section and islet autoimmunity was observed at the pathway level, with a correlation of 0.49 (p = 0.02, Figure 4D+E ), supporting the functional agreement of transcriptional changes between the two risk factors. Importantly, we did not observe that children born by Cesarean section developed islet autoantibodies more frequently than children born by vaginal delivery, ruling out a confounding effect not related to gene expression (Supplemental file 1: Table S1 ).
In contrast to the profound Cesarean section to islet autoantibodies correlation at transcript level, we found the effects of gender, maternal diabetes and multiple first-degree relatives to be randomly In summary, this analysis showed that the gene expression changes in these two risk factors, Cesarean section and islet autoimmunity, are remarkably coherent.
Signatures of immune cell activation
The pentose phosphate pathway is a universal, central metabolic pathway in the cytosol, which supports cell proliferation and survival [15] . The non-oxidative branch of the pentose phosphate pathway branches off glycolysis and generates ribose 5-phosphate as a precursor for the synthesis of nucleotides and amino acids necessary for cell growth and division. Moreover, the pyrimidine metabolism pathway is directly related to the pentose phosphate pathway in its role in nucleotide synthesis. Since we investigated PMBCs, these differentially regulated pathways in Cesarean section and islet autoimmunity point toward a general activation of immune cells. A direct proof of this hypothesis in the same children was unfeasible in the context of this study. Instead, we collected evidence from several secondary analysis steps.
First, we investigated whether regulated genes from both analyses enriched immune genes annotated in innateDB [16] . Indeed, there was a significant accumulation of higher standardized effects for immune genes compared to non-immune genes, for both Cesarean section (Wilcoxon rank sum test: p = 0.0002) and autoimmunity (p = 2.6 x 10 −15 ); see Supplemental file 6.
Second, we compared results from the mixture of PBMC cells with published data on activation in isolated immune cells. For the analysis, we used transcriptomics data from isolated naïve and activated human CD4+ T cells [17] . We calculated gene expression differences before and after activation, and applied enrichment analysis to identify differentially expressed pathways. In particular, the "Pentose Detailed results are shown in Supplemental file 7.
In summary, we observed a significant correlation between the functional effects of human lymphocyte activation and the effects of Cesarean section and islet autoimmunity on gene expression in PBMCs.
Discussion
We identified coherent gene expression signatures for Cesarean section, an early risk factor for type 1 diabetes, and islet autoantibody positivity, an obligatory stage of autoimmune response prior to the development of autoimmune type 1 diabetes. Specifically, at the transcriptome level, we identified two 
Conclusions
In summary, we found a transcriptional link between Cesarean section and islet autoimmunity, pointing toward a transiently altered immune system in the susceptible period of islet autoimmunity generated by Cesarean section, which was remarkably coherent with the changes observed after islet autoimmunity.
Methods
PBMC gene expression data
We used the BABYDIET PBMC gene expression data deposited in ArrayExpress (accession number: E-MTAB-1724) [6] , in combination with non-public data on Cesarean section, islet autoimmunity, family history, gender and age. In this data set, 454 samples from 109 children were available. One individual of the original 109 children was removed in the Cesarean section analysis, since no information about the type of delivery was recorded. Raw gene expression data of 33,297 probes were normalized using the Robust Multi-Array Average (RMA) method [19] . Probes without annotation in the Affymetrix hugene11 data and duplicates were removed using the R package genefilter, leaving 18,720 genes for further analysis. Age at sampling ranged from 0.21 years to 9.15 years, with a median of 1.53 years.
Generalized additive mixed model for time-resolved data
Transcriptomics samples were available for multiple time points per child. To model gene expression from multiple, non-matching timepoints in relation to Cesarean section in a joint approach, we employed a generalized additive mixed model (GAMM) [20] . In this GAMM, the model structure is defined as In addition, we included a random effect as 45,"~ (0, " ), with " estimated per gene, correcting for the dependence of several measurements per child, denoted as , , and an error term ",$ as i.i.d.
normally distributed noise. The noise ",$ and the noise of the subject specific random effect " were assumed to be independent. Inference of the GAMM was performed using a restricted maximum likelihood approach [21] using the R package mgcv.
Linear model for seroconversion analysis
To investigate differences in gene expression between children after development of islet autoantibodies and age-matched children who did not develop islet autoantibodies, we selected the first sample up to six months after development of islet autoimmunity for each child, when such a sample was available (see Figure 1B) . These children were compared to all available age-matched children who did not develop autoantibodies, by applying a linear regression model per gene:
where ",$ is the gene expression of child j for gene i, (," the intercept, AB," describes the effect on gene expression of islet autoimmunity, with , = 1 for islet autoantibody-positives and , = 0 for islet autoantibody-negatives, and EFG," the effect of age , on gene expression. The residual term ",$ was defined as i.i.d. normally distributed noise.
Pathway enrichment analysis
We performed pathway enrichment analysis based on the KEGG database [12] . We identified differentially regulated pathways using the "Significance Analysis of Function and Expression" (SAFE)
algorithm [22] , R package safe. In this approach, p-values from local gene tests are computed and
Wilcoxon rank sum statistics assess whether local statistics are systematically increased in the pathway, compared to the background (global test). Local gene tests were calculated on the residuals of models from equations (1) and (2), but excluding the term for the factor of interest (Cesarean section or islet autoimmunity). SAFE uses a sample permutation-based approach for p-value calculation, which avoids false positive results due to correlating transcripts. The number of permutations was set to 5,000.
For node coloring of pathways ( Figure 4A+B ), we used a "directed p-value", defined as (-log10(p-value) * sign(regression coefficient)). For nodes in the pathway that had multiple genes annotated, the highest effect was shown.
Comparing Cesarean section and islet autoimmunity results
To compare the results obtained from the Cesarean section and islet autoimmunity (Ab+) analyses, we calculated the Pearson correlation between the standardized effect estimates of both analyses.
Standardized effect estimates were represented by the t-statistic in the single gene analysis, and a "directed p-value" (analogously to previous section) in the pathway analysis. To assess the statistical significance of the correlation, we calculated permutations was repeated for the factors maternal diabetes, gender, and multiple first-degree relatives.
Immune cell activation analysis
To investigate the enrichment of genes within annotated immune genes from innateDB [16] , we calculated Wilcoxon rank sum tests using the t-statistics from the single gene level analysis (see above)
to identify differences between the distribution of immune genes and non-immune genes. For comparison of standardized effects, we used two published datasets, one from isolated CD4+ T cells before and after activation (GEOD-33272, processed data downloaded) and one containing different subsets of human leukocytes before and after activation (GEOD-22886, processed data downloaded).
Single gene differential analysis was performed on log2-transformed expression values using linear regression, with gene expression as the response, and activation status as the explaining variables. For SAFE pathway enrichment, the number of permutations was set to 1,000. To calculate permutationbased p-values of Pearson correlations, we used 1,000 permutations.
All statistical analyses were performed using the computing environment R version 3. 
